| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.81B | +23.8% |
| Cost of Revenue | $2.91B | +24.7% |
| Gross Profit | $898.7M | +20.9% |
| R&D Expense | $45.1M | -3.0% |
| SG&A Expense | $592.3M | +3.8% |
| Pre-tax Income | $196.8M | +28.9% |
| Income Tax | $40.2M | +4.7% |
| Net Income | $155.0M | +36.8% |
| EPS (Basic) | $0.77 | +37.5% |
| EPS (Diluted) | $0.75 | +38.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $250.2M | -0.6% |
| Accounts Receivable | $601.1M | +2.8% |
| Inventory | $542.5M | -0.1% |
| Current Assets | $1.50B | +2.6% |
| Total Assets | $3.39B | -4.2% |
| Current Liabilities | $859.0M | +7.1% |
| Long-term Debt | $648.4M | -11.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $413.4M | +25.9% |
| Capital Expenditures | $102.8M | +21.7% |
| Investing Cash Flow | -$88.0M | -135.2% |
| Financing Cash Flow | -$324.8M | -38.6% |
| Free Cash Flow | $310.6M | +27.4% |
| Total Liabilities |
| $1.71B |
| -3.9% |
| Stockholders' Equity | $1.69B | -4.3% |